{"id":6014,"date":"2022-04-14T09:18:30","date_gmt":"2022-04-14T07:18:30","guid":{"rendered":"https:\/\/www.rapharm.eu\/hr\/?p=6014"},"modified":"2022-04-19T14:43:37","modified_gmt":"2022-04-19T12:43:37","slug":"eu-strucne-skupine-za-medicinske-proizvode-i-in-vitro-dijagnostiku-prenesene-u-europsku-agenciju-za-lijekove-ema","status":"publish","type":"post","link":"https:\/\/www.rapharm.eu\/hr\/eu-strucne-skupine-za-medicinske-proizvode-i-in-vitro-dijagnostiku-prenesene-u-europsku-agenciju-za-lijekove-ema\/","title":{"rendered":"EU: Stru\u010dne skupine za medicinske proizvode i in vitro dijagnostiku prenesene u Europsku agenciju za lijekove (EMA)"},"content":{"rendered":"<style type=\"text\/css\"><\/style>\n<p>1. o\u017eujka Tajni\u0161tvo stru\u010dnih skupina Komisije\nza medicinske proizvode i <em>in vitro<\/em> dijagnosti\u010dke medicinske proizvode preba\u010deno\nje iz Zajedni\u010dkog istra\u017eiva\u010dkog centra (JRC) na Europsku agenciju za lijekove\n(EMA).<\/p>\n\n\n\n<p>Glavna uprava za\nzdravlje i sigurnost hrane (DG SANTE) povjerila je JRC-u da uspostavi skupine,\ndefinira smjernice dokumenta, operativne tijekove rada i potrebne IT alate, kao\ni da pokrene njihove obvezne savjetodavne funkcije.<\/p>\n\n\n\n<p>Pozadina primopredaje je poja\u010dana uloga EMA-e\nu pripravnosti za krizne situacije i upravljanju njima u podru\u010dju lijekova i\nmedicinskih proizvoda (Uredba (EU) 2022\/123), razvijena kao reakcija na\npandemiju COVID-19 u EU.<\/p>\n\n\n\n<p>Za vi\u0161e informacija pogledajte <a href=\"https:\/\/t19a9129c.emailsys2a.net\/c\/175\/5190201\/4329\/0\/21309371\/48461\/312401\/94e6172f36.html\">ovdje<\/a>.<\/p>\n\n\n\n<p><strong>Trebate li dodatno znanje ili pomo\u0107 u ispunjavanju\nzahtjeva MDR\/IVDR?<\/strong><\/p>\n\n\n\n<p>Uz pomo\u0107 na\u0161ih <a href=\"https:\/\/www.rapharm.eu\/hr\/aktualna-obrazovanja\/\">aktualnih obrazovanja<\/a> i <a href=\"https:\/\/www.rapharm.eu\/hr\/savjetovanje-i-usluge\/\">savjetovanja<\/a>\nmo\u017eemo vam u potpunosti pomo\u0107i u ispunjavanju zahtjeva MDR\/IVDR.<\/p>\n\n\n\n<p><strong>Vir:<\/strong><\/p>\n\n\n\n<p><a href=\"https:\/\/ec.europa.eu\/health\/system\/files\/2022-03\/md_handover-panels_en_1.pdf\">Handover\nof expert panels on medical devices and in vitro diagnostics from the\nCommission\u2019s Joint Research Centre (JRC) to the European Medicines Agency (EMA)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>1. o\u017eujka Tajni\u0161tvo stru\u010dnih skupina Komisije za medicinske proizvode i in vitro dijagnosti\u010dke medicinske proizvode preba\u010deno je iz Zajedni\u010dkog istra\u017eiva\u010dkog centra (JRC) na Europsku agenciju za lijekove (EMA). Glavna uprava za zdravlje i sigurnost hrane (DG SANTE) povjerila je JRC-u da uspostavi skupine, definira smjernice dokumenta, operativne tijekove rada i potrebne IT alate, kao i&#8230;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[46],"tags":[],"class_list":["post-6014","post","type-post","status-publish","format-standard","hentry","category-novice-hr"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>EU: Stru\u010dne skupine za medicinske proizvode i in vitro dijagnostiku prenesene u Europsku agenciju za lijekove (EMA) - raPHARM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/\" \/>\n<meta property=\"og:locale\" content=\"hr_HR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU: Stru\u010dne skupine za medicinske proizvode i in vitro dijagnostiku prenesene u Europsku agenciju za lijekove (EMA) - raPHARM\" \/>\n<meta property=\"og:description\" content=\"1. o\u017eujka Tajni\u0161tvo stru\u010dnih skupina Komisije za medicinske proizvode i in vitro dijagnosti\u010dke medicinske proizvode preba\u010deno je iz Zajedni\u010dkog istra\u017eiva\u010dkog centra (JRC) na Europsku agenciju za lijekove (EMA). Glavna uprava za zdravlje i sigurnost hrane (DG SANTE) povjerila je JRC-u da uspostavi skupine, definira smjernice dokumenta, operativne tijekove rada i potrebne IT alate, kao i...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/\" \/>\n<meta property=\"og:site_name\" content=\"raPHARM\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-14T07:18:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-19T12:43:37+00:00\" \/>\n<meta name=\"author\" content=\"rapharm\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"rapharm\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/\",\"url\":\"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/\",\"name\":\"EU: Stru\u010dne skupine za medicinske proizvode i in vitro dijagnostiku prenesene u Europsku agenciju za lijekove (EMA) - raPHARM\",\"isPartOf\":{\"@id\":\"https:\/\/www.rapharm.eu\/#website\"},\"datePublished\":\"2022-04-14T07:18:30+00:00\",\"dateModified\":\"2022-04-19T12:43:37+00:00\",\"author\":{\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/#breadcrumb\"},\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.rapharm.eu\/hr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU: Stru\u010dne skupine za medicinske proizvode i in vitro dijagnostiku prenesene u Europsku agenciju za lijekove (EMA)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rapharm.eu\/#website\",\"url\":\"https:\/\/www.rapharm.eu\/\",\"name\":\"raPHARM\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rapharm.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1\",\"name\":\"rapharm\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g\",\"caption\":\"rapharm\"},\"url\":\"https:\/\/www.rapharm.eu\/hr\/author\/rapharm\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EU: Stru\u010dne skupine za medicinske proizvode i in vitro dijagnostiku prenesene u Europsku agenciju za lijekove (EMA) - raPHARM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/","og_locale":"hr_HR","og_type":"article","og_title":"EU: Stru\u010dne skupine za medicinske proizvode i in vitro dijagnostiku prenesene u Europsku agenciju za lijekove (EMA) - raPHARM","og_description":"1. o\u017eujka Tajni\u0161tvo stru\u010dnih skupina Komisije za medicinske proizvode i in vitro dijagnosti\u010dke medicinske proizvode preba\u010deno je iz Zajedni\u010dkog istra\u017eiva\u010dkog centra (JRC) na Europsku agenciju za lijekove (EMA). Glavna uprava za zdravlje i sigurnost hrane (DG SANTE) povjerila je JRC-u da uspostavi skupine, definira smjernice dokumenta, operativne tijekove rada i potrebne IT alate, kao i...","og_url":"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/","og_site_name":"raPHARM","article_published_time":"2022-04-14T07:18:30+00:00","article_modified_time":"2022-04-19T12:43:37+00:00","author":"rapharm","twitter_card":"summary_large_image","twitter_misc":{"Written by":"rapharm","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/","url":"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/","name":"EU: Stru\u010dne skupine za medicinske proizvode i in vitro dijagnostiku prenesene u Europsku agenciju za lijekove (EMA) - raPHARM","isPartOf":{"@id":"https:\/\/www.rapharm.eu\/#website"},"datePublished":"2022-04-14T07:18:30+00:00","dateModified":"2022-04-19T12:43:37+00:00","author":{"@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1"},"breadcrumb":{"@id":"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/#breadcrumb"},"inLanguage":"hr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rapharm.eu\/hr\/"},{"@type":"ListItem","position":2,"name":"EU: Stru\u010dne skupine za medicinske proizvode i in vitro dijagnostiku prenesene u Europsku agenciju za lijekove (EMA)"}]},{"@type":"WebSite","@id":"https:\/\/www.rapharm.eu\/#website","url":"https:\/\/www.rapharm.eu\/","name":"raPHARM","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rapharm.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hr"},{"@type":"Person","@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1","name":"rapharm","image":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g","caption":"rapharm"},"url":"https:\/\/www.rapharm.eu\/hr\/author\/rapharm\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/posts\/6014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/comments?post=6014"}],"version-history":[{"count":1,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/posts\/6014\/revisions"}],"predecessor-version":[{"id":6015,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/posts\/6014\/revisions\/6015"}],"wp:attachment":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/media?parent=6014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/categories?post=6014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/tags?post=6014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}